6 results
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
causing COVID-19 ... #Coronavirus #SARS-CoV ... InfectiousDiseases #CriticalCare ... #EmergencyMedicine ... #Pharmacology #Treatment
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... most effective treatments ... #CoronaVirus #Treatment ... #Pharmacology #CriticalCare ... #EmergencyMedicine
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... COVID-19 • Virus ... 31 • First US case ... #CriticalCare
Extrapulmonary manifestations of COVID-19
 • Neurologic: Headaches, Dizziness, Encephalopathy, Guillain-Barré, Ageusia, Myalgia, Anosmia, Stroke
 • Renal:
manifestations of COVID ... -19 • Neurologic ... Encephalopathy, Guillain-Barré ... Gastrointestinal: Diarrhea, Nausea ... Symptoms #SARSCOV2 #coronavirus
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Epidemiology: • 1-2 cases ... like illnesses, COVID ... 19 - Zika virus ... Treatment: • Plasmapheresis ... #neurology
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... Incidence: 1 to 2 cases ... and cauda equina TREATMENT ... GBS #Guillain #Barre ... diagnosis #management #neurology